Morgan Stanley Upgrades Insulet to Overweight, Raises Price Target to $234
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Patrick Wood upgraded Insulet (NASDAQ:PODD) from Equal-Weight to Overweight and increased the price target from $185 to $234.
December 04, 2023 | 12:27 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Insulet's stock rating was upgraded by Morgan Stanley from Equal-Weight to Overweight, with a price target increase from $185 to $234.
Upgrades by major analysts like Morgan Stanley can lead to increased investor confidence and a potential rise in stock price. The substantial increase in the price target suggests a positive outlook on the company's performance and future prospects.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100